DK123288A - Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen - Google Patents

Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen

Info

Publication number
DK123288A
DK123288A DK123288A DK123288A DK123288A DK 123288 A DK123288 A DK 123288A DK 123288 A DK123288 A DK 123288A DK 123288 A DK123288 A DK 123288A DK 123288 A DK123288 A DK 123288A
Authority
DK
Denmark
Prior art keywords
antigen
procedure
surface antigen
recombinant hepatitis
yeast
Prior art date
Application number
DK123288A
Other languages
Danish (da)
English (en)
Other versions
DK123288D0 (da
Inventor
William M Hurni
Dennis J Kubek
William J Miller
Mark S Rienstra
Edward M Scolnick
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK123288D0 publication Critical patent/DK123288D0/da
Publication of DK123288A publication Critical patent/DK123288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
DK123288A 1987-03-09 1988-03-08 Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen DK123288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2334787A 1987-03-09 1987-03-09

Publications (2)

Publication Number Publication Date
DK123288D0 DK123288D0 (da) 1988-03-08
DK123288A true DK123288A (da) 1988-09-10

Family

ID=21814559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK123288A DK123288A (da) 1987-03-09 1988-03-08 Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen

Country Status (10)

Country Link
EP (1) EP0291146B1 (fr)
JP (1) JPS63270629A (fr)
AT (1) ATE93891T1 (fr)
AU (1) AU608813B2 (fr)
CA (1) CA1304887C (fr)
CY (1) CY1790A (fr)
DE (1) DE3883596T2 (fr)
DK (1) DK123288A (fr)
ES (1) ES2043808T3 (fr)
HK (1) HK48094A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960023066A (ko) * 1994-12-10 1996-07-18 성재갑 전에스 (s) 2 펩티드 함유 비 (b) 형 간염 표면항원의 정제 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
EP0401941A3 (fr) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Antigène de surface du virus de l'hépatite B, et sa production
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
JPS62298536A (ja) * 1986-06-17 1987-12-25 Green Cross Corp:The 生理活性物質の自動精製方法および自動精製装置
DE3882154T2 (de) * 1987-02-27 1993-12-02 Merck & Co Inc Verfahren zur Herstellung des pres 1/S2/S-Hepatitis-B-Antigens aus Hefe.

Also Published As

Publication number Publication date
DE3883596T2 (de) 1994-02-17
ATE93891T1 (de) 1993-09-15
JPS63270629A (ja) 1988-11-08
CA1304887C (fr) 1992-07-07
AU1277888A (en) 1988-09-08
AU608813B2 (en) 1991-04-18
DE3883596D1 (de) 1993-10-07
EP0291146B1 (fr) 1993-09-01
EP0291146A2 (fr) 1988-11-17
HK48094A (en) 1994-05-20
DK123288D0 (da) 1988-03-08
EP0291146A3 (en) 1989-12-06
ES2043808T3 (es) 1994-01-01
CY1790A (en) 1995-10-20

Similar Documents

Publication Publication Date Title
ATE224956T1 (de) Verfahren zur verstärkten expression von virusproteinen
DK383189A (da) Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer
CA2020668A1 (fr) Proteines fusionnees ou hybrides comprenant de la lymphokine et un antigene viral
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
ATE91714T1 (de) Transformation von trichoderma.
ATE97164T1 (de) Rekombinantes vaccinia-virus mva.
IL90035A (en) Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants
DK235289D0 (da) Ekspression af hapatitis b s- og praes2-proteiner i methylotrophe gaerarter
AU580059B2 (en) Vaccine against rabies and preparation process thereof
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ATE121754T1 (de) Vakzine gegen bordetella.
DK123288A (da) Fremgangsmaade til remsning af rekombinant hepatitis b overfladeantigen
ATE209252T1 (de) Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
DK373489D0 (da) Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler
DE3587205D1 (de) Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
DK100888D0 (da) Fremgangsmaade til at rense rekombinant pres-1/s-2/s hepatitis b antigen fra gaer
DK43991D0 (da) Allele varianter af plasmodium falciparum merozoitoverfladeantigen
EP0293201A3 (fr) Méthode de vaccination contre le virus de l'hépatite B
PT89041A (pt) Metodo de preparacao de diagnosticos e vacinas nanbv
ATE159758T1 (de) Azelluläre impfstoffe
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment